Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Centurion Minerals: Advancing a High-potential Gold Project in...

Top 5 Silver News Stories of 2025

LaFleur Minerals Announces Non-Brokered Private Placement for Gross...

SQM, Codelco Seal Landmark Lithium Joint Venture in...

Managing Director Resignation and Board Changes

Rick Rule, Ed Steer, Vince Lanci and More...